Inicio・Lista de Acciones・Compugen Ltd

Compugen Ltd

Cerrado

2.35 0.43

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

2.27

Máximo

2.37

Métricas clave
By Trading Economics
Ingresos	-65M -7.7M
Ventas	-65M 2.2M
P/B Media del Sector	5.95 64.641
BPA	-0.08
Margen de beneficios	-352.436
Empleados	75
EBITDA	-64M -7.7M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 Meses	+112.77% upside

Dividendos
By Acuity
Próximas Ganancias	3 ago 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-45M 225M
Apertura anterior	1.92
Cierre anterior	2.35

Compugen Ltd Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

2 ago 2026, 23:51 UTC

Cautious Optimism Surrounds Upcoming South Korea Manufacturing PMI Release Amid Mixed Economic Signals and Regional Trends

2 ago 2026, 23:51 UTC

Japan's Upcoming Current Account Release on August 9, 2026, Expected to Reflect Export-Import Balance Amidst Cautiously Optimistic Market Sentiment.

2 ago 2026, 23:51 UTC

Correlated Moves

Macro News

Bitcoin is trading higher, influenced by rising crude oil prices and positive tech stock performance. Ethereum's increase also supports Bitcoin's upward movement today.

2 ago 2026, 23:31 UTC

Bitcoin and Ethereum rise amid market volatility and geopolitical tensions, as investors brace for potential Fed rate hikes and key economic data releases.

2 ago 2026, 23:31 UTC

Bitcoin and Ethereum rise amid market volatility, while momentum trading strategies face significant drawdowns as the Fed's steady interest rates and geopolitical tensions influence investor sentiment.

2 ago 2026, 23:31 UTC

Bitcoin and Ethereum rise amid geopolitical tensions and potential U.S. rate hikes, as investors brace for key labor market data.

2 ago 2026, 23:31 UTC

Bitcoin and Ethereum rise amid declining momentum trading strategies, while geopolitical tensions and inflation concerns heighten expectations for a potential Federal Reserve interest rate hike.

2 ago 2026, 23:21 UTC

Social Media

Correlated Moves

Macro News

Geopolitical tensions and rising fuel prices are driving demand for gold. Gold has gained modestly since Friday, with silver also rising today.

2 ago 2026, 23:02 UTC

Correlated Moves

AUD/CAD is higher in after-market trading, reflecting a modest gain since Friday's close and correlating with a rise in AUD/USD.

2 ago 2026, 23:01 UTC

Correlated Moves

Gold/JPY is advancing during Sunday’s session, supported by rising gold prices. The pair remains below its 20-day moving average amid ongoing market volatility.

2 ago 2026, 23:01 UTC

Correlated Moves

Macro News

EUR/USD rises in after-market trading, reflecting market reactions to potential U.S. monetary policy changes and concerns about a financial crisis linked to AI developments.

2 ago 2026, 23:01 UTC

Copper is trading higher during Sunday’s session, maintaining strength despite a slight pullback from earlier gains. It remains above its 20-day moving average.

2 ago 2026, 23:01 UTC

GBP/NOK is trading higher in after-market hours, reflecting a shift in trading dynamics despite recent market volatility and being near the lower end of its one-month range.

2 ago 2026, 23:01 UTC

Correlated Moves

Silver prices are advancing today, reflecting a broader upward movement in precious metals, despite earlier intraday volatility. Gold's increase may support silver's rise.

2 ago 2026, 23:01 UTC

Correlated Moves

Gold/NZD is higher today, recovering from an earlier low and reflecting a similar rise in gold prices since Friday's close.

2 ago 2026, 23:01 UTC

Correlated Moves

Silver/CHF is trading higher, recovering from earlier lows and reflecting a strong upward trajectory since Friday's close, in line with rising gold prices.

2 ago 2026, 23:01 UTC

Macro News

The Nikkei 225 Index is lower in after-market hours, continuing a decline linked to a weaker yen and potential interest rate hikes amid inflation concerns.

2 ago 2026, 23:01 UTC

Correlated Moves

Silver/GBP is trading higher, recovering from an earlier dip. The asset has increased notably since Friday's close, reflecting a strong correlation with gold.

2 ago 2026, 23:01 UTC

Correlated Moves

Gold/CAD is trading higher, rebounding from earlier losses amid rising silver prices. Broader market sentiment shows a decline in momentum trading strategies.

2 ago 2026, 23:01 UTC

Correlated Moves

The S&P 500 Index is trading higher, continuing a trend of three consecutive positive sessions, supported by gains in the Dow Jones Index.

2 ago 2026, 23:01 UTC

Correlated Moves

Silver/JPY is trading higher amid market volatility, reflecting a notable increase. The rise aligns with a gain in gold, indicating a strong correlation.

2 ago 2026, 23:01 UTC

Correlated Moves

Silver/SGD is trading higher, reflecting a broader rise in precious metals. Earlier, the asset pulled back but has since rebounded from session lows.

2 ago 2026, 23:01 UTC

Correlated Moves

Gold/AUD is rising today, supported by an increase in Gold (XAU/USD). The price remains near the lower end of its one-month trading range.

2 ago 2026, 23:01 UTC

Correlated Moves

Gold/CHF is advancing, reflecting gains in Gold (XAU/USD) and macroeconomic factors. Recent market volatility continues to influence investor risk sentiment.

2 ago 2026, 23:01 UTC

Correlated Moves

Gold/GBP is trading higher, recovering from an earlier dip amid increased Gold prices and shifts in investor sentiment during market volatility.

2 ago 2026, 23:01 UTC

Correlated Moves

Silver/NZD is trading higher, recovering from earlier fluctuations, as gold prices rise. It remains about 1.03% below its 20-day moving average.

2 ago 2026, 23:01 UTC

Correlated Moves

Silver/HKD is trading higher today, supported by a rise in gold prices. Earlier, it experienced notable volatility but has since recovered above Friday's close.

2 ago 2026, 23:01 UTC

Macro News

The US 5Y Treasury Bond Index is higher, recovering from an early dip amid Federal Reserve discussions on interest rate hikes and inflation concerns.

2 ago 2026, 23:01 UTC

Correlated Moves

Silver Ounce vs Euro shows notable gains today, driven by rising gold prices. Earlier, XAG/EUR pulled back from a session high but remains elevated.

2 ago 2026, 23:01 UTC

Correlated Moves

Gold/HKD is higher today, reflecting a modest gain since Friday's close amid broader market volatility and heightened investor anxiety.

Comparación entre iguales

Cambio de precio

Compugen Ltd previsión

Precio Objetivo

By TipRanks

112.77% repunte

Estimación a 12 Meses

Media 5 USD 112.77%

Máximo 6 USD

Mínimo 4 USD

De acuerdo con 3 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Compugen Ltd Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

3 ratings

Comprar

Mantener

Vender

De acuerdo con 3 analistas que ofrecen calificaciones bursátiles a para Compugen Ltd Dist en los últimos 3 meses.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Compugen Ltd

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I monotherapy clinical study in patients with advanced malignancies through sequential dose escalations; Bapotulimab, a therapeutic antibody targeting ILDR2 that is in Phase I clinical study in patients with naïve head and neck squamous cell carcinoma; and Rilvegostomig, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase II clinical study in patients with advanced or metastatic non-small cell lung cancer. Its therapeutic pipeline also includes early-stage immuno-oncology programs focused to address various mechanisms of immune resistance; and COM503, high affinity antibody, which blocks the interaction between IL-18 binding protein and IL-18. The company has collaboration agreement with Bayer Pharma AG for the research, development, and commercialization of antibody-based therapeutics against the company's immune checkpoint regulators; Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors; and Johns Hopkins School of Medicine to evaluate novel T cell and myeloid checkpoint targets. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and research collaboration with Johns Hopkins University for myeloid. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.